Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2026-02-25 @ 10:05 PM
Study NCT ID:
NCT02024633
Status:
UNKNOWN
Last Update Posted:
2015-07-15
First Post:
2013-12-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer
Sponsor:
Betta Pharmaceuticals Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BD-IC-IV48
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None